← Back

Wire · regulatory

FDA's FY2027 Device Guidance Agenda Prioritizes AI And Surgical Robots, But Delivery Is The Test

Published

5 October 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at insights.citeline.com →

◆ Verified

Fusion42 · 6 October 2026 · Fusion42 review

The FDA's FY2027 guidance agenda focuses on developing regulatory frameworks for AI and surgical robots in medical devices, with public feedback open until November 30, 2026.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Medical device founders specialising in AI and surgical robots face a live window to influence FDA rules before November 30. Early engagement can secure smoother approvals and position your tech ahead of peers.

◆ Coverage

1 source · 5 Oct 2026

◆ Related on Wire

◆ Topics

MedtechFDAmedical-devicesAIsurgical-robotsregulationguidance